Myocardial Performance Index for Detection of Subclinical Abnormalities in Patients with Sarcoidosis
Overview
Affiliations
Aim: The aim of this study was to evaluate ventricular functions in patients with sarcoidosis without an obvious heart disease by using tissue Doppler-derived left and right ventricular myocardial performance index (MPI).
Methods: The study population included 45 patient with sarcoidosis (29 men, 16 women; mean age, 44±10 years, mean disease duration, 4.2±2.7 years) and 45 healthy control subjects (31 men, 14 women; mean age, 41±8 years). Cardiac functions were determined using echocardiography, consisting of standard two-dimensional and conventional Doppler and tissue Doppler imaging (TDI). Myocardial tissue Doppler velocities [peak systolic (Sa), early diastolic (Ea), and late diastolic velocities (Aa)] were recorded using spectral pulsed Doppler from the LV free wall, septum, and RV free wall from the apical four chamber view. MPI was also calculated by TDI.
Results: The conventional echocardiographic parameters and tissue Doppler measurements were similar between the patients and controls. Left ventricular MPI (0.490±0.092 vs. 0.396±0.088, P=0.010) and right ventricular MPI (0.482±0.132 vs. 0.368±0.090, P=0.006) were significantly higher in patients with sarcoidosis than the control subjects. There was a correlation between the disease duration and right and left ventricular MPI (r=0.418, P=0.005; r=0.366, P=0.013, respectively). There was also a correlation between the systolic pulmonary arterial pressure and right ventricular MPI but not left ventricular MPI (r=0.370, P=0.012; r=0.248, P=0.109, respectively). In receiver operating characteristics curve analysis, the cutoff value of left ventricular MPI >0.46 had 92% sensitivity and 64% specificity in predicting left ventricular diastolic dysfunction.
Conclusions: We have demonstrated that tissue Doppler-derived myocardial left and right ventricular MPI were impaired in sarcoidosis patients, although systolic function parameters were comparable in the patients and controls, showed a subclinic impaired ventricular functions in patients with sarcoidosis.
Oksen D, Aslan M BMJ Open Diabetes Res Care. 2024; 12(3).
PMID: 38886070 PMC: 11184181. DOI: 10.1136/bmjdrc-2024-004153.
Rao S, Jain D, Singh T Indian Heart J. 2020; 72(4):330-331.
PMID: 32861399 PMC: 7474106. DOI: 10.1016/j.ihj.2020.05.006.
Ito T, Akamatsu K, Fujita S, Kanzaki Y, Ukimura A, Hoshiga M PLoS One. 2019; 14(8):e0221628.
PMID: 31442264 PMC: 6707632. DOI: 10.1371/journal.pone.0221628.
Biering-Sorensen T, Mogelvang R, Knegt M, Olsen F, Galatius S, Skov Jensen J PLoS One. 2016; 11(4):e0153636.
PMID: 27093636 PMC: 4836694. DOI: 10.1371/journal.pone.0153636.
Biering-Sorensen T, Mogelvang R, Schnohr P, Skov Jensen J J Am Heart Assoc. 2016; 5(1).
PMID: 26786544 PMC: 4859387. DOI: 10.1161/JAHA.115.002687.